Regulation and Dysregulation of Endothelial Permeability during Systemic Inflammation.

Katharina E M Hellenthal, Laura Brabenec, Nana-Maria Wagner
Author Information
  1. Katharina E M Hellenthal: Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, 48149 Muenster, Germany. ORCID
  2. Laura Brabenec: Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, 48149 Muenster, Germany. ORCID
  3. Nana-Maria Wagner: Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Muenster, 48149 Muenster, Germany. ORCID

Abstract

Systemic inflammation can be triggered by infection, surgery, trauma or burns. During systemic inflammation, an overshooting immune response induces tissue damage resulting in organ dysfunction and mortality. Endothelial cells make up the inner lining of all blood vessels and are critically involved in maintaining organ integrity by regulating tissue perfusion. Permeability of the endothelial monolayer is strictly controlled and highly organ-specific, forming continuous, fenestrated and discontinuous capillaries that orchestrate the extravasation of fluids, proteins and solutes to maintain organ homeostasis. In the physiological state, the endothelial barrier is maintained by the glycocalyx, extracellular matrix and intercellular junctions including adherens and tight junctions. As endothelial cells are constantly sensing and responding to the extracellular environment, their activation by inflammatory stimuli promotes a loss of endothelial barrier function, which has been identified as a hallmark of systemic inflammation, leading to tissue edema formation and hypotension and thus, is a key contributor to lethal outcomes. In this review, we provide a comprehensive summary of the major players, such as the angiopoietin-Tie2 signaling axis, adrenomedullin and vascular endothelial (VE-) cadherin, that substantially contribute to the regulation and dysregulation of endothelial permeability during systemic inflammation and elucidate treatment strategies targeting the preservation of vascular integrity.

Keywords

References

  1. J Cell Biol. 1989 Nov;109(5):2455-62 [PMID: 2530239]
  2. Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2643-52 [PMID: 21885850]
  3. Nat Commun. 2016 Jan 27;7:10493 [PMID: 26814335]
  4. Microcirculation. 1998;5(2-3):197-210 [PMID: 9789260]
  5. Clin Sci (Lond). 2005 Jul;109(1):97-102 [PMID: 15740458]
  6. Exp Cell Res. 2007 Jul 1;313(11):2504-20 [PMID: 17493609]
  7. Clin Chim Acta. 2002 Sep;323(1-2):17-29 [PMID: 12135804]
  8. Biochem Biophys Res Commun. 1993 Apr 30;192(2):553-60 [PMID: 8387282]
  9. Crit Care Med. 1998 Jun;26(6):1001-6 [PMID: 9635646]
  10. J Virol. 2008 Jun;82(12):5797-806 [PMID: 18367532]
  11. Nat Commun. 2015 Apr 10;6:6725 [PMID: 25857352]
  12. Ann Thorac Surg. 2017 Jan;103(1):32-40 [PMID: 27884410]
  13. Pflugers Arch. 2007 Jun;454(3):345-59 [PMID: 17256154]
  14. Lancet. 1993 Feb 27;341(8844):515-8 [PMID: 8094770]
  15. Oncogene. 1992 Aug;7(8):1471-80 [PMID: 1630810]
  16. Cardiovasc Res. 2012 Oct 1;96(1):140-9 [PMID: 22843705]
  17. Ann Lab Med. 2014 Jul;34(4):263-73 [PMID: 24982830]
  18. J Exp Med. 2011 Aug 1;208(8):1721-35 [PMID: 21788407]
  19. JAMA. 2016 Feb 23;315(8):801-10 [PMID: 26903338]
  20. Microsc Res Tech. 2000 Nov 1;51(3):280-301 [PMID: 11054877]
  21. Oncogene. 1999 Oct 21;18(43):5948-53 [PMID: 10557082]
  22. Basic Res Cardiol. 2015 Mar;110(2):6 [PMID: 25600227]
  23. Am J Physiol Lung Cell Mol Physiol. 2001 Apr;280(4):L732-8 [PMID: 11238014]
  24. Curr Opin Hematol. 2017 Sep;24(5):432-438 [PMID: 28582314]
  25. Biochem Biophys Res Commun. 1994 Jun 30;201(3):1160-6 [PMID: 8024557]
  26. Shock. 2018 Dec;50(6):648-654 [PMID: 29324627]
  27. Acta Physiol (Oxf). 2017 Feb;219(2):441-452 [PMID: 27096875]
  28. J Cell Physiol. 1989 Apr;139(1):157-66 [PMID: 2540209]
  29. Crit Care Med. 2010 Sep;38(9):1845-51 [PMID: 20581666]
  30. Sci Transl Med. 2016 Apr 20;8(335):335ra55 [PMID: 27099174]
  31. Elife. 2016 Jan 19;5:e11394 [PMID: 26780829]
  32. Dev Dyn. 2010 Dec;239(12):3303-11 [PMID: 20941780]
  33. ACS Pharmacol Transl Sci. 2020 Mar 20;3(2):263-284 [PMID: 32296767]
  34. Am J Respir Crit Care Med. 2022 Jun 14;: [PMID: 35699655]
  35. Nat Rev Immunol. 2015 Nov;15(11):692-704 [PMID: 26471775]
  36. J Intern Med. 2015 Mar;277(3):277-293 [PMID: 25418337]
  37. J Cell Biol. 2013 Sep 16;202(6):901-16 [PMID: 24019534]
  38. Curr Opin Crit Care. 2014 Dec;20(6):588-95 [PMID: 25320909]
  39. Br J Pharmacol. 2010 Jan 1;159(2):253-64 [PMID: 20002097]
  40. Br J Pharmacol. 1998 Apr;123(8):1645-54 [PMID: 9605572]
  41. J Biol Chem. 1998 Jul 3;273(27):16730-8 [PMID: 9642228]
  42. Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):223-32 [PMID: 18162609]
  43. J Exp Med. 2015 Dec 14;212(13):2267-87 [PMID: 26642851]
  44. J Intensive Care. 2014 Jun 20;2(1):38 [PMID: 25908988]
  45. Cold Spring Harb Perspect Biol. 2012 Dec 01;4(12): [PMID: 23209152]
  46. Cardiovasc Res. 2017 May 01;113(6):671-680 [PMID: 28453727]
  47. Mol Cell Biol. 2006 Apr;26(7):2511-8 [PMID: 16537897]
  48. N Engl J Med. 2010 Aug 12;363(7):689-91 [PMID: 20818861]
  49. Annu Rev Cell Dev Biol. 2019 Oct 6;35:591-613 [PMID: 31299172]
  50. Biomed Res Int. 2017;2017:6130725 [PMID: 28255555]
  51. Anaesthesiol Intensive Ther. 2014 Nov-Dec;46(5):361-80 [PMID: 25432556]
  52. Ann N Y Acad Sci. 2001;936:426-37 [PMID: 11460496]
  53. Chest. 2017 Aug;152(2):312-320 [PMID: 28411114]
  54. Dev Cell. 2004 May;6(5):709-17 [PMID: 15130495]
  55. Intensive Care Med. 2007 Apr;33(4):703-10 [PMID: 17318497]
  56. Sci Transl Med. 2010 Mar 17;2(23):23ra19 [PMID: 20375003]
  57. Am J Respir Crit Care Med. 2019 Dec 15;200(12):1472-1476 [PMID: 31381867]
  58. Ophthalmology. 2015 Mar;122(3):545-54 [PMID: 25439435]
  59. J Cell Sci. 2015 Aug 15;128(16):3041-54 [PMID: 26116572]
  60. Shock. 2018 Aug;50(2):132-140 [PMID: 29324626]
  61. J Clin Endocrinol Metab. 2001 Jan;86(1):396-404 [PMID: 11232031]
  62. Cell Adh Migr. 2014;8(2):158-64 [PMID: 25422846]
  63. Am J Physiol. 1998 Sep;275(3):F410-4 [PMID: 9729514]
  64. Crit Care Med. 2021 Jan 1;49(1):e41-e52 [PMID: 33196529]
  65. Biopharm Drug Dispos. 2007 Sep;28(6):315-22 [PMID: 17575559]
  66. Blood. 2005 Mar 1;105(5):1950-5 [PMID: 15374886]
  67. Genes Dev. 1994 Aug 15;8(16):1897-909 [PMID: 7958865]
  68. Am J Pathol. 2014 Nov;184(11):3069-83 [PMID: 25251058]
  69. Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):615-9 [PMID: 11149956]
  70. AJNR Am J Neuroradiol. 2013 Mar;34(3):518-23 [PMID: 22918429]
  71. Intensive Care Med Exp. 2013 Dec;1(1):21 [PMID: 26266790]
  72. Crit Care Med. 2002 Oct;30(10):2313-21 [PMID: 12394961]
  73. Crit Care. 2018 Dec 21;22(1):354 [PMID: 30583748]
  74. Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15062-6 [PMID: 11734623]
  75. Biochem Biophys Res Commun. 1995 Feb 6;207(1):25-32 [PMID: 7857273]
  76. Eur J Pharmacol. 1993 Sep 14;241(2-3):271-3 [PMID: 8243562]
  77. Crit Care Med. 2014 Oct;42(10):e654-62 [PMID: 25083983]
  78. Crit Care. 2014 Feb 17;18(1):R34 [PMID: 24533868]
  79. J Clin Endocrinol Metab. 1997 Jan;82(1):95-100 [PMID: 8989240]
  80. Nat Rev Immunol. 2007 Oct;7(10):803-15 [PMID: 17893694]
  81. Am J Physiol. 1991 May;260(5 Pt 1):C1052-9 [PMID: 1709785]
  82. PLoS Pathog. 2014 Mar 06;10(3):e1003980 [PMID: 24603727]
  83. BMC Med. 2011 Sep 22;9:107 [PMID: 21936959]
  84. Peptides. 2001 Dec;22(12):2099-103 [PMID: 11786196]
  85. Intensive Care Med. 2021 Nov;47(11):1284-1294 [PMID: 34605947]
  86. Integr Biol (Camb). 2017 Jun 19;9(6):529-538 [PMID: 28488717]
  87. BMC Endocr Disord. 2010 Apr 22;10:7 [PMID: 20412573]
  88. Crit Care Med. 2021 Nov 1;49(11):e1063-e1143 [PMID: 34605781]
  89. Endocrinology. 1994 Dec;135(6):2454-8 [PMID: 7988431]
  90. Trends Mol Med. 2013 Jan;19(1):31-9 [PMID: 23182855]
  91. J Pept Sci. 2015 Dec;21(12):905-12 [PMID: 26767744]
  92. Blood. 2003 May 15;101(10):3765-77 [PMID: 12543869]
  93. Crit Care. 2005;9(6):R816-24 [PMID: 16356231]
  94. Sci Rep. 2016 Sep 19;6:33495 [PMID: 27640364]
  95. Br J Anaesth. 2022 May;128(5):864-873 [PMID: 35131096]
  96. Diabetes Obes Metab. 2018 Feb;20 Suppl 1:34-46 [PMID: 29364584]
  97. Peptides. 2011 Jul;32(7):1540-50 [PMID: 21645567]
  98. Physiol Rev. 2019 Jul 1;99(3):1467-1525 [PMID: 31140373]
  99. Crit Care Med. 2002 May;30(5 Suppl):S207-13 [PMID: 12004237]
  100. Cell. 2004 Apr 16;117(2):157-69 [PMID: 15084255]
  101. Biochem Soc Trans. 2002 Aug;30(4):432-7 [PMID: 12196109]
  102. Crit Care. 2017 Nov 13;21(1):274 [PMID: 29132435]
  103. PLoS One. 2009;4(3):e4912 [PMID: 19300530]
  104. J Clin Invest. 2016 Sep 1;126(9):3495-510 [PMID: 27548530]
  105. Crit Care Med. 2008 May;36(5):1637-40 [PMID: 18434892]
  106. Front Immunol. 2018 Apr 24;9:838 [PMID: 29740443]
  107. Ann Intensive Care. 2016 Dec;6(1):116 [PMID: 27878573]
  108. FEBS Lett. 2000 Jan 21;466(1):155-9 [PMID: 10648832]
  109. Nat Rev Nephrol. 2019 Feb;15(2):87-108 [PMID: 30607032]
  110. Nat Rev Immunol. 2020 Jul;20(7):389-391 [PMID: 32439870]
  111. Genes Dev. 2004 May 1;18(9):1060-71 [PMID: 15132996]
  112. J Am Soc Nephrol. 2017 Jul;28(7):1973-1982 [PMID: 28465380]
  113. Blood. 2011 Jan 20;117(3):942-52 [PMID: 21030556]
  114. J Clin Invest. 2013 Jul 1;: [PMID: 23863629]
  115. J Biol Chem. 2009 Feb 20;284(8):5381-94 [PMID: 19095647]
  116. Am J Physiol Heart Circ Physiol. 2007 Nov;293(5):H2667-79 [PMID: 17693543]
  117. Circ Res. 2001 Jul 6;89(1):63-70 [PMID: 11440979]
  118. Ann Thorac Surg. 2017 Jul;104(1):161-169 [PMID: 28193536]
  119. Kidney Int. 1999 Jun;55(6):2362-7 [PMID: 10354283]
  120. Crit Care. 2011;15(5):R261 [PMID: 22040774]
  121. Oncogene. 2007 Feb 15;26(7):1067-77 [PMID: 16909109]
  122. Free Radic Biol Med. 2021 Jan;162:14-26 [PMID: 33271281]
  123. Sci Rep. 2015 Jun 05;5:11030 [PMID: 26046800]
  124. Nat Rev Mol Cell Biol. 2016 Aug;17(8):496-510 [PMID: 27301673]
  125. Elife. 2021 Jun 22;10: [PMID: 34154705]
  126. Biol Chem. 2016 Jun 1;397(6):497-506 [PMID: 26872312]
  127. Lancet. 2020 Jan 18;395(10219):200-211 [PMID: 31954465]
  128. Circulation. 2005 Jan 4;111(1):97-105 [PMID: 15611372]
  129. Trends Mol Med. 2021 Apr;27(4):314-331 [PMID: 33309601]
  130. FEBS Lett. 1998 Apr 17;426(2):233-7 [PMID: 9599015]
  131. J Gerontol A Biol Sci Med Sci. 2006 Oct;61(10):1051-2 [PMID: 17077197]
  132. Nat Immunol. 2014 Mar;15(3):223-30 [PMID: 24487320]
  133. Clin Chem. 2009 Sep;55(9):1672-9 [PMID: 19574469]
  134. J Vasc Res. 1997 May-Jun;34(3):212-9 [PMID: 9226303]
  135. Crit Care. 2016 Jun 09;20(1):178 [PMID: 27282767]
  136. Clin Infect Dis. 2009 Sep 15;49(6):841-9 [PMID: 19673614]
  137. Shock. 2010 Mar;33(3):263-8 [PMID: 19543148]
  138. Physiol Rev. 2006 Jan;86(1):279-367 [PMID: 16371600]
  139. Int J Clin Pract. 2019 Oct;73(10):e13394 [PMID: 31332896]
  140. Br J Anaesth. 2007 Dec;99(6):830-6 [PMID: 17962242]
  141. Sci Rep. 2016 Jun 30;6:29003 [PMID: 27357373]
  142. Prog Mol Biol Transl Sci. 2013;116:119-44 [PMID: 23481193]
  143. Nat Rev Immunol. 2007 Sep;7(9):678-89 [PMID: 17717539]
  144. J Biol Chem. 2007 Aug 17;282(33):23910-8 [PMID: 17562701]
  145. Dev Biol. 2005 Nov 15;287(2):301-13 [PMID: 16225857]
  146. Cell Mol Life Sci. 2017 May;74(10):1871-1881 [PMID: 28025672]
  147. Nat Rev Dis Primers. 2019 Mar 14;5(1):18 [PMID: 30872586]
  148. Br J Clin Pharmacol. 2020 May;86(5):979-990 [PMID: 31912513]
  149. Eur J Pharmacol. 2015 Oct 5;764:140-148 [PMID: 26144371]
  150. Neuron. 1993 Mar;10(3):409-26 [PMID: 8461134]
  151. Crit Care Med. 2005 Apr;33(4):819-26 [PMID: 15818111]
  152. Crit Care Med. 2004 Aug;32(8):1715-21 [PMID: 15286549]
  153. Crit Care Med. 2012 Nov;40(11):3034-41 [PMID: 22890252]
  154. Angiogenesis. 2008;11(2):109-19 [PMID: 18293091]
  155. Annu Rev Biomed Eng. 2007;9:121-67 [PMID: 17373886]
  156. Anesth Analg. 2020 Dec;131(6):1693-1707 [PMID: 33186158]
  157. Intensive Care Med Exp. 2013 Dec;1(1):22 [PMID: 26266791]
  158. J Cell Physiol. 2008 Jun;215(3):715-24 [PMID: 18064650]
  159. Lymphat Res Biol. 2008;6(3-4):109-22 [PMID: 19093783]
  160. Crit Rev Immunol. 2015;35(4):277-91 [PMID: 26757392]
  161. J Clin Invest. 2014 Oct;124(10):4564-76 [PMID: 25180601]
  162. Vascul Pharmacol. 2002 Nov;39(4-5):213-23 [PMID: 12747961]
  163. Br J Pharmacol. 2013 May;169(1):143-55 [PMID: 23351143]
  164. Front Physiol. 2019 Jul 31;10:945 [PMID: 31417415]
  165. Cardiovasc Res. 2016 Sep;111(4):398-409 [PMID: 27307317]
  166. Blood. 2004 Jun 1;103(11):4150-6 [PMID: 14976056]
  167. Biochem J. 2004 Nov 1;383(Pt. 3):413-8 [PMID: 15307819]
  168. Kidney Int. 2009 Dec;76(11):1180-91 [PMID: 19812542]
  169. Biorheology. 2019;56(2-3):131-149 [PMID: 30988234]
  170. Surg Infect (Larchmt). 2001 Fall;2(3):193-202; discussion 202-3 [PMID: 12593709]
  171. Crit Care. 2017 Jul 5;21(1):163 [PMID: 28676101]
  172. Anesth Analg. 2017 Mar;124(3):836-845 [PMID: 27655274]
  173. Vascul Pharmacol. 2002 Nov;39(4-5):187-99 [PMID: 12747959]
  174. Shock. 2007 Dec;28(6):650-654 [PMID: 18092380]
  175. Annu Rev Pathol. 2016 May 23;11:251-81 [PMID: 26907525]
  176. Circ Res. 2002 Oct 4;91(7):618-25 [PMID: 12364390]
  177. Dev Cell. 2008 Jan;14(1):25-36 [PMID: 18194650]
  178. Am J Respir Crit Care Med. 2021 Jan 15;203(2):202-210 [PMID: 32757963]
  179. Crit Care. 2014 Jun 16;18(3):152 [PMID: 25041977]
  180. Shock. 2015 Mar;43(3):212-21 [PMID: 25423128]
  181. J Biol Chem. 2005 Sep 9;280(36):31906-12 [PMID: 16027153]
  182. J Trauma. 2010 May;68(5):1121-7 [PMID: 20038857]
  183. Crit Care. 2012 Oct 04;16(5):R182 [PMID: 23036162]
  184. Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 2):S39-45 [PMID: 11734465]
  185. Circ Res. 1998 Oct 19;83(8):852-9 [PMID: 9776732]
  186. Peptides. 1997;18(5):733-9 [PMID: 9213369]
  187. Cytokine. 2011 Aug;55(2):251-9 [PMID: 21531574]
  188. PLoS One. 2008 Feb 20;3(2):e1649 [PMID: 18297135]
  189. Kidney Int. 2012 May;81(10):942-948 [PMID: 21814177]
  190. Br J Pharmacol. 2012 May;166(1):66-78 [PMID: 21871019]
  191. Am J Respir Crit Care Med. 2011 May 15;183(10):1344-53 [PMID: 21257790]

MeSH Term

Capillary Permeability
Endothelial Cells
Endothelium, Vascular
Humans
Inflammation
Permeability

Word Cloud

Created with Highcharts 10.0.0endothelialinflammationsystemictissueorganvascularSystemicEndothelialcellsintegrityPermeabilitybarrierextracellularjunctionsangiopoietin-Tie2adrenomedullinpermeabilitycantriggeredinfectionsurgerytraumaburnsovershootingimmuneresponseinducesdamageresultingdysfunctionmortalitymakeinnerliningbloodvesselscriticallyinvolvedmaintainingregulatingperfusionmonolayerstrictlycontrolledhighlyorgan-specificformingcontinuousfenestrateddiscontinuouscapillariesorchestrateextravasationfluidsproteinssolutesmaintainhomeostasisphysiologicalstatemaintainedglycocalyxmatrixintercellularincludingadherenstightconstantlysensingrespondingenvironmentactivationinflammatorystimulipromoteslossfunctionidentifiedhallmarkleadingedemaformationhypotensionthuskeycontributorlethaloutcomesreviewprovidecomprehensivesummarymajorplayerssignalingaxisVE-cadherinsubstantiallycontributeregulationdysregulationelucidatetreatmentstrategiestargetingpreservationRegulationDysregulationInflammationcapillaryleakageendotheliumprocalcitonin

Similar Articles

Cited By